New hope for tough liver cancers: trial tests Next-Line combo
Disease control
Not yet recruiting
This study is for people with advanced liver cancer that has spread or cannot be removed by surgery, and whose cancer has gotten worse after their first treatment, which included a type of immunotherapy. It will test if adding a new investigational drug called visugromab to a sta…
Phase: PHASE2 • Sponsor: CatalYm GmbH • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC